Mobilization, collection, and immunomagnetic selection of peripheral blood CD34 cells in recovered aplastic anemia patients

Transfusion

Volumn 47, Issue 7, 2007, Pages 1250-1253

  Sloand, Elaine M ^a   Read, Elizabeth J ^a   Scheinberg, Phillip ^a   Tang, Yong ^a   More, Kenneth ^a   Leitman, Susan F ^a   Maciejewski, Jaroslaw ^a   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CD34 SELECTION; CELL COUNT; CELL ISOLATION; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; FEASIBILITY STUDY; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; LEUKAPHERESIS; PERIPHERAL BLOOD STEM CELL; SCHOOL CHILD; STEM CELL MOBILIZATION;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; ANTIGENS, CD34; CHILD; FEASIBILITY STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOMAGNETIC SEPARATION; LEUKAPHERESIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 34250662988     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01258.x     Document Type: Article

References (19)

1. Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H. Antithymocyte glodulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood 2003 101 : 1236 42.
2. Rosenfeld S, Follmann D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 2003 289 : 1130 5.
3. Socie G, Rosenfeld S, Frickhofen N, Gluckman E, Tichelli A. Late clonal diseases of treated aplastic anemia. Semin Hematol 2000 37 : 91 101.
4. Maciejewski JP, Risitano A, Sloand EM, Nunez O, Young NS. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood 2002 99 : 3129 35.
5. Tisdale JF, Dunn DE, Rosenfeld SE, et al. A preliminary report on a randomized trial comparing ATG and cyclosporine vs. cyclophosphamide and cyclosporine as initial treatment for severe aplastic anemia [abstract]. Blood 1998 10 (Suppl 1 24b 25b.
6. Maciejewski JP, Kim S, Sloand E, Selleri C, Young NS. Sustained long-term hematologic recovery despite a marked quantitative defect in the stem cell compartment of patients with aplastic anemia after immunosuppressive therapy. Am J Hematol 2000 65 : 123 31.
7. Sloand EM, Kim S, Fuhrer M, et al. Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities. Blood 2002 100 : 4427 32.
8. Kozuka T, Ikeda K, Teshima T, et al. Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors. Transfusion 2004 44 : 526 32.
9. Schmitz N, Barrett J. Optimizing engraftment - source and dose of stem cells. Semin Hematol 2002 39 : 3 14.
10. Maciejewski JP, Selleri C, Tadatsugu S, Anderson S, Young NS. A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. Blood 1996 88 : 1983 91.
11. Suzuya H, Watanabe T, Nakagawa R, et al. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors. Vox Sang 2005 89 : 229 35.
12. Lysak D, Koza V, Jindra P. Factors affecting PBSC mobilization and collection in healthy donors. Transfus Apher Sci 2005 33 : 275 83.
13. Moncada V, Bolan C, Yau YY, Leitman SF. Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim. Transfusion 2003 43 : 495 501.
14. Bacigalupo A, Piaggio G, Podesta M, et al. Collection of peripheral blood hematopoietic progenitors (PBHP) from patients with severe aplastic anemia (SAA) after prolonged administration of granulocyte colony-stimulating factor. Blood 1993 82 : 1410 4.
15. Linker C, Anderlini P, Herzig R, et al. Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation. Biol Blood Marrow Transplant 2003 9 : 405 13.
16. Gajewski JL, Rondon G, Donato ML, et al. Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization. Biol Blood Marrow Transplant 2002 8 : 550 6.
17. Heimfeld S, Fogarty B, McGuire K, Williams S, Berenson RJ. Peripheral blood stem cell mobilization after stem cell factor or G-CSF treatment: rapid enrichment for stem and progenitor cells using the CEPRATE immunoaffinity separation system. Transplant Proc 1992 24 : 2818.
18. Liles WC, Rodger E, Broxmeyer HE, et al. Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist. Transfusion 2005 45 : 295 300.
19. Liles WC, Broxmeyer HE, Rodger E, et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003 102 : 2728 30.